News Boston Biodevelopment, Regulatory Consultants, Sponsor 7th Annual Gene Therapy for Rare Disorders Summit Mar 20, 2024 Posted by Boston Biodevelopment LLC
News Greenberg Traurig’s Bradley A. Jacobson Presents at PLI’s Private Placements and Hybrid Securities Offerings 2024 Mar 15, 2024 Posted by Greenberg Traurig, LLP
News Greenberg Traurig’s Zachary A. Dovitz Selected for Greater Boston Chamber of Commerce’s 2024 Boston Future Leaders Program Mar 15, 2024 Posted by Greenberg Traurig, LLP
News Novel Bio and Culture Biosciences | Scale-up NBx Platform™ for plasmid DNA production Mar 07, 2024 Posted by Culture Biosciences
News Live Seminar: Tools for Optimizing Human Immune Cell Research Mar 04, 2024 Posted by Prendio LLC
News CULLINAN ONCOLOGY ANNOUNCES U.S. FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR NOVEL MICA/B ANTIBODY, CLN-619, FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA Mar 01, 2024 Posted by Cullinan Therapeutics
